3-(Benzylamino)-1-butanol | 121006-14-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(Benzylamino)-1-butanol
• 英文别名: 3-benzylamino-butan-1-ol；N-Benzyl-3-amino-1-butanol；3-(Benzylamino)butan-1-ol
• CAS: 121006-14-2；121006-15-3；98014-58-5
• 化学式: C₁₁H₁₇NO
• mdl: MFCD20617488
• 分子量: 179.262
• InChiKey: DYGQWKBWKAFSBR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  32.3
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(Benzylamino)-1-butanol 在 咪唑 、 氯化亚砜 、 三乙胺 、 ruthenium trichloride 、 sodium periodate 作用下， 以 二氯甲烷 、 氯仿 、 水 、 乙腈 为溶剂， 以9.1 g的产率得到(+/-)-3-benzyl-4-methyl-[1,2,3]oxathiazinane-2,2-dioxide
  参考文献：
  名称：

  一种使用[1,2-环氨基磺酸]不对称合成烷基取代的哌啶-2-酮的[3 + 3]环化策略：从L-正缬氨酸正式合成（S）-甜菜碱

  摘要：

  一组代表性的1,2-环氨基磺酸盐与原丙酸三乙酯的区域选择性开环反应在酸性水解后有效地进行，以递送相应的δ-氨基-α，β-不饱和酯。不饱和酯的氢化和随后的热环化提供了相关的烷基取代的哌啶-2-酮。这种方法代表了一种新的[3 + 3]环化策略，用于烷基取代的哌啶-2-酮的不对称合成。由1-正缬氨酸的形式不对称合成（S）-丝氨酸说明了环化过程的效率。

  DOI：

  10.1016/j.tet.2012.09.081
• 作为产物：
  描述：

  甲基(RS)-3-(N-苄基氨基)丁酸酯 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 3.0h， 以92%的产率得到3-(Benzylamino)-1-butanol
  参考文献：
  名称：

  Synthesis of 1-Alkyl-2-(trifluoromethyl)azetidines and Their Regiospecific Ring Opening toward Diverse α-(Trifluoromethyl)Amines via Intermediate Azetidinium Salts

  摘要：

  A convenient approach toward nonactivated 1-alkyl-2-(trifluoromethyl)azetidines as a new class of constrained azaheterocycles was developed staffing from ethyl 4,4,4-trifluoroacetoacetate via imination, hydride reduction, chlorination, and base-induced ring closure. Furthermore, the reactivity profile of these 2-CF3-azetidines was assessed by means of quaternization and subsequent regiospecific ring opening at C4 of the azetidinium intermediates by oxygen, nitrogen, carbon, sulfur, and halogen nucleophiles, pointing to a clear difference in reactivity compared to azetidines bearing other types of electron-withdrawing groups at C2.

  DOI：

  10.1021/jo300694y

文献信息

• [EN] METHODS FOR PREPARING FLUOROALKYL ARYLSULFINYL COMPOUNDS AND FLUORINATED COMPOUNDS THERETO<br/>[FR] PROCÉDÉS DE PRÉPARATION DE COMPOSÉS FLUOROALKYLE ARYLSULFINYLÉS ET COMPOSÉS FLUORÉS APPARENTÉS
  申请人：IM & T RES INC

  公开号：WO2010022001A1

  公开（公告）日：2010-02-25

  Novel preparative methods for fluoroalkyl arylsulfinyl compounds are disclosed. Fluorinated compounds as useful fluorinated compounds, intermediates, or builing blocks are disclosed. Useful applications of the fluoroalkyl arylsulfinyl compounds are shown.

  揭示了用于制备氟烷基芳基磺酰基化合物的新型制备方法。公开了氟化合物作为有用的氟化合物、中间体或构建块。展示了氟烷基芳基磺酰基化合物的有用应用。
• [EN] 3-[1,4]OXAZEPANE-4-PYRIMIDONE DERIVATIVES<br/>[FR] DÉRIVÉS DE 3-[1,4] OXAZÉPANE-4-PYRIMIDONE
  申请人：MITSUBISHI TANABE PHARMA CORP

  公开号：WO2010114179A1

  公开（公告）日：2010-10-07

  A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein Z represents nitrogen atom, C-F or the like; R1 represents a C1-C3 alkyl group; Y represents oxygen atom or N-R7; R2, R3, R4, R5, R6 and R7 each independently represents hydrogen atom, a C1-C6 alkyl group, or a group represented by the formula (II): which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).

  化合物的化学式为（I）或其药学上可接受的盐：其中Z代表氮原子，C-F或类似物；R1代表C1-C3烷基基团；Y代表氧原子或N-R7；R2、R3、R4、R5、R6和R7分别独立地代表氢原子，C1-C6烷基基团，或由化学式（II）表示的基团：该化合物用于预防和/或治疗由tau蛋白激酶1过度活化引起的疾病，如神经退行性疾病（例如阿尔茨海默病）。
• Methods For Preparing Fluoroalkyl Arylsulfinyl Compounds And Fluorinated Compounds Thereto
  申请人：Umemoto Teruo

  公开号：US20110190511A1

  公开（公告）日：2011-08-04

  Novel preparative methods for fluoroalkyl arylsulfinyl compounds are disclosed. Fluorinated compounds as useful fluorinated compounds, intermediates, or builing blocks are disclosed. Useful applications of the fluoroalkyl arylsulfinyl compounds are shown.

  本发明揭示了一种用于制备氟烷基芳基亚磺酰化合物的新型制备方法。本发明还揭示了氟化合物作为有用的氟化合物、中间体或构建块。同时，本发明还展示了氟烷基芳基亚磺酰化合物的有用应用。
• Methods for Preparing Fluoroalkyl Arylsulfinyl Compounds and Fluorinated Compounds Thereto
  申请人：Umemoto Teruo

  公开号：US20100152463A1

  公开（公告）日：2010-06-17

  Novel preparative methods for fluoroalkyl arylsulfinyl compounds are disclosed. Fluorinated compounds as useful fluorinated compounds, intermediates, or building blocks are disclosed. Useful applications of the fluoroalkyl arylsulfinyl compounds are shown.

  本发明公开了用于制备氟烷基芳基磺酰基化合物的新型制备方法。本发明还公开了作为有用的氟化合物、中间体或构建块的氟化合物。本发明还展示了氟烷基芳基磺酰基化合物的有用应用。
• 3-[1,4]OXAZEPANE-4-PYRIMIDONE DERIVATIVES
  申请人：Watanabe Kazutoshi

  公开号：US20120095216A1

  公开（公告）日：2012-04-19

  A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein Z represents nitrogen atom, C—F or the like; R 1 represents a C 1 -C 3 alkyl group; Y represents oxygen atom or N—R 7 ; R 2 , R 3 , R 4 , R 5 , R 6 and R 7 each independently represents hydrogen atom, a C 1 -C 6 alkyl group, or a group represented by the formula (II): which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).

  化合物的化学式为（I）或其药学上可接受的盐，用于治疗由tau蛋白激酶1过度活化引起的疾病，例如神经退行性疾病（如阿尔茨海默病）。其中，Z代表氮原子、C—F或类似物；R1代表C1-C3烷基；Y代表氧原子或N—R7；R2、R3、R4、R5、R6和R7各自独立地代表氢原子、C1-C6烷基或由式（II）表示的基团。